ENTRADA THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $277.4M | $84.6M |
| Jun 2022 | — | $256.0M | $90.9M |
| Sep 2022 | — | $233.2M | $53.3M |
| Dec 2022 | — | $212.6M | $45.2M |
| Mar 2023 | — | $229.6M | $227.6M |
| Jun 2023 | — | $206.9M | $79.7M |
| Sep 2023 | — | $246.7M | $51.9M |
| Dec 2023 | — | $242.4M | $67.6M |
| Mar 2024 | — | $269.4M | $68.4M |
| Jun 2024 | — | $429.9M | $185.3M |
| Sep 2024 | — | $422.4M | $78.0M |
| Dec 2024 | — | $428.7M | $101.2M |
| Mar 2025 | — | $417.3M | $67.8M |
| Jun 2025 | — | $379.5M | $72.5M |
| Sep 2025 | — | $340.7M | $93.3M |
| Dec 2025 | — | $306.1M | $90.4M |
| Mar 2026 | — | $270.9M | $76.4M |
| Jun 2026 | — | $233.4M | $99.3M |